TEVA
Teva Pharma Industries Ltd
36.80$
+0.7%
vs. previous close
Closing price · As of: Aug 14, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 57.7% | 56.3% | 57.0% | 54.5% | 55.0% | 59.2% | 56.5% | 53.6% | 53.3% | 52.8% | 49.3% | 48.2% | 46.2% | 47.0% | 43.8% | 48.0% | 47.6% | 47.3% | 45.5% | 42.2% | 45.9% | 51.6% | 56.0% | 55.4% | 53.6% | 52.2% | 53.3% | 51.8% | 51.3% | 48.2% | |
| 42.3% | 43.7% | 43.0% | 45.5% | 45.0% | 40.8% | 43.5% | 46.4% | 46.7% | 47.2% | 50.7% | 51.8% | 53.8% | 53.0% | 56.2% | 52.0% | 52.4% | 52.7% | 54.5% | 57.8% | 54.1% | 48.4% | 44.0% | 44.6% | 46.4% | 47.8% | 46.7% | 48.2% | 48.7% | 51.8% | |
| 6.6% | 5.8% | 6.1% | 6.4% | 6.0% | 5.2% | 6.6% | 6.5% | 7.1% | 7.0% | 5.9% | 6.2% | 7.1% | 5.8% | 5.8% | 6.0% | 6.7% | 7.0% | 7.3% | 7.8% | 9.6% | 8.3% | 6.4% | 6.0% | 10.8% | 6.9% | 5.6% | 6.0% | 6.4% | 5.9% | |
| – | – | – | – | 23.5% | 22.7% | 22.7% | 22.4% | 21.6% | 3.8% | 24.6% | 26.4% | 6.0% | 5.9% | 5.4% | 5.1% | 6.1% | 6.1% | 6.0% | 6.3% | 5.6% | 5.9% | 6.9% | 7.1% | 7.0% | 6.9% | 7.9% | 7.3% | 7.0% | 7.5% | |
| 28.7% | 28.1% | 30.0% | 30.0% | 23.5% | 22.7% | 22.7% | 19.4% | 22.2% | 22.2% | 25.7% | 26.4% | 43.5% | 30.9% | 29.6% | 30.1% | 31.9% | 33.2% | 32.4% | 31.8% | 32.9% | 30.5% | 28.8% | 47.2% | 67.8% | 37.0% | 61.4% | 28.1% | 50.6% | 39.3% | |
| 13.6% | 15.6% | 13.0% | 15.5% | 14.0% | 17.4% | 20.8% | 26.8% | 12.0% | 25.0% | 9.5% | 25.5% | 10.3% | 17.3% | 24.0% | 17.0% | 10.9% | 8.1% | 19.5% | 17.1% | 9.8% | -78.1% | -8.7% | -2.6% | -21.4% | 10.8% | -14.7% | 2.7% | -1.8% | 12.5% | |
| 4.8% | 3.8% | 6.0% | 3.5% | 11.0% | 2.1% | 0.7% | 2.5% | 25.0% | 0.1% | 32.1% | 1.2% | 2.9% | 1.7% | 1.4% | 0.8% | 1.7% | 1.4% | 1.4% | 2.4% | 6.1% | 4.0% | 4.7% | 5.7% | 4.5% | 5.6% | 6.2% | 6.5% | 5.7% | 5.3% | |
| 9.9% | 12.6% | 8.9% | 12.6% | 11.9% | 16.5% | 19.8% | 26.6% | 12.6% | 24.9% | 8.4% | 25.0% | 7.5% | 15.9% | 22.6% | 16.1% | 9.0% | 6.2% | 17.9% | 12.0% | 3.8% | -82.1% | -13.8% | -4.3% | -23.6% | 4.2% | -21.1% | -3.9% | -7.8% | 7.2% | |
| 2.2% | 3.5% | 2.8% | 3.5% | 3.4% | 3.1% | 3.4% | 5.5% | 5.6% | 4.5% | 1.8% | 4.2% | 1.7% | 1.2% | 1.8% | 0.7% | -0.7% | -0.2% | 2.9% | 3.2% | 2.4% | -8.6% | -1.0% | 1.6% | 1.0% | 1.3% | -4.3% | -0.4% | 4.1% | -1.0% | |
| 7.7% | 9.1% | 6.2% | 9.2% | 8.5% | 13.4% | 16.3% | 21.1% | 6.9% | 20.4% | 6.5% | 20.7% | 5.7% | 14.4% | 20.7% | 15.1% | 9.7% | 6.2% | 15.1% | 8.1% | 1.5% | -72.7% | -11.4% | -5.9% | -24.0% | 2.6% | -16.4% | -3.5% | -9.9% | 8.2% | |
| 18.1% | 20.2% | 23.5% | 26.2% | 26.9% | 23.4% | 20.8% | 30.9% | 29.0% | 29.6% | 30.1% | 25.5% | 14.8% | 17.3% | 29.9% | 23.3% | 19.1% | 15.8% | 29.5% | 32.3% | 13.1% | -69.3% | 1.0% | 26.3% | 27.7% | 27.8% | -6.2% | 2.7% | 26.8% | 18.2% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.